HDAC as a therapeutic target for treatment of endometrial cancers.
Ren J, Zhang J, Cai H, Li Y, Zhang Y, Zhang X, Zhao D, Li Z, Ma H, Wang J, Gao YE, Xiao L, Liu R, Qian J, Liu Y, Wei H, Li J.
Ren J, et al. Among authors: cai h.
Curr Pharm Des. 2014;20(11):1847-56. doi: 10.2174/13816128113199990528.
Curr Pharm Des. 2014.
PMID: 23888962
Review.